A high-throughput genetic screen designed to establish new kinases involved in CRPC [22] identified the NEK6 protein as a central kinase that mediates androgen-independent tumor growth and determined that NEK6 is aberrantly expressed in human prostate cancer and several prostate cancer cell lines. Here, NEK6 is linked to neoplasm.